[Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin]
- PMID: 11521657
[Control of a school outbreak of serogroup B meningococcal disease by chemoprophylaxis with azithromycin and ciprofloxacin]
Abstract
Objective: To assess the efficacy of azithromycin as a chemoprophylactic agent in meningococcal disease in pre-school aged children, and the safety of ciprofloxacin in children aged 6-16 years old.
Methods: After classic chemoprophylaxis with rifampicin failed to control a school outbreak of meningococcal disease in Cantabria (Spain), a second cycle of chemoprophylaxis was administered in the school. Azithromycin was administered in the nursery level (99 children, aged 3-5 years old) and ciprofloxacin was administered in the primary and secondary levels (795 children, aged 6-16 years old) and in the school's adult personnel (58 persons). The efficacy of chemoprophylaxis was studied through records of cases of meningococcal disease, the mandatory disease reporting system, and the school's absences. The safety of ciprofloxacin was studied using a questionnaire designed to determine the incidence of adverse osteoarticular effects, which was distributed to parents, school personnel and pediatricians within the school's area.
Results: The chemoprophylaxis administered controlled the outbreak. We collected 764 questionnaIres (response rate: 89.5 %). The incidence of arthralgia after ciprofloxacin was 0.9% in children and 3.3% in adults. All were mild and self-limiting without specific treatment, except in one patient (in the adult group) in whom arthralgia was present 1 month after prophylactic treatment. However, the arthralgia was so mild that the patient had not consulted her physician. Only three children had sought medical advice for arthralgia. Consequently, the incidence that would have been detected by the Spanish pharmacovigilance system would have been 0.4% in children and 0% in adults.
Conclusions: Azithromycin was effective in controlling the outbreak in children aged between 3 and 5 years. Ciprofloxacin was safe and effective, with no serious or persistent osteoarticular effects in children. The incidence of arthralgia was lower in children than in adults.
Comment in
-
[Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin].An Esp Pediatr. 2001 May;54(5):525-6. An Esp Pediatr. 2001. PMID: 11333489 Spanish. No abstract available.
Similar articles
-
[Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin].An Esp Pediatr. 2001 May;54(5):525-6. An Esp Pediatr. 2001. PMID: 11333489 Spanish. No abstract available.
-
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085. Pediatrics. 2006. PMID: 16740809
-
Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.Postgrad Med J. 2008 Feb;84(988):87-92. doi: 10.1136/pgmj.2007.065680. Postgrad Med J. 2008. PMID: 18322129
-
Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.Respir Med. 2007 Oct;101(10):2037-43. doi: 10.1016/j.rmed.2007.06.030. Epub 2007 Aug 13. Respir Med. 2007. PMID: 17706408 Review.
-
Ciprofloxacin in meningococcal carriers.Scand J Infect Dis Suppl. 1989;60:108-11. Scand J Infect Dis Suppl. 1989. PMID: 2667102 Review.
Cited by
-
Antibiotics for preventing meningococcal infections.Cochrane Database Syst Rev. 2013 Oct 25;2013(10):CD004785. doi: 10.1002/14651858.CD004785.pub5. Cochrane Database Syst Rev. 2013. PMID: 24163051 Free PMC article.
-
Prophylactic use of antibiotics for prevention of meningococcal infections: systematic review and meta-analysis of randomised trials.Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):172-81. doi: 10.1007/s10096-005-1297-7. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15782277
-
Prospects for vaccine prevention of meningococcal infection.Clin Microbiol Rev. 2006 Jan;19(1):142-64. doi: 10.1128/CMR.19.1.142-164.2006. Clin Microbiol Rev. 2006. PMID: 16418528 Free PMC article. Review.
-
Risk and prevention of meningococcal disease among education workers: A review.Can J Infect Dis. 2004 Mar;15(2):89-93. doi: 10.1155/2004/370415. Can J Infect Dis. 2004. PMID: 18159482 Free PMC article.
-
Mass chemoprophylaxis for control of outbreaks of meningococcal disease.Lancet Infect Dis. 2018 Sep;18(9):e272-e281. doi: 10.1016/S1473-3099(18)30124-5. Epub 2018 May 29. Lancet Infect Dis. 2018. PMID: 29858150 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical